IQVIA has entered a strategic collaboration with Amazon Web Services, naming AWS its Preferred Agentic Cloud Provider and setting the stage for a major shift in how AI supports clinical research and healthcare

Become a Member

Members have access to all articles.

Membership
analytics. The agreement will see IQVIA deploy its agentic AI platform on AWS to enhance automation across clinical trial operations, medical affairs workflows, and data-driven insights. 

Lucas Glass, SVP of Architecture and Standards at IQVIA, said, “We are excited to move forward with AWS as IQVIA’s Preferred Agentic Cloud Provider. Our AI platform aims to empower life sciences organizations to innovate faster and deliver treatments to patients more efficiently.”

AWS will provide the cloud scale and technical depth required to support next-generation life sciences solutions, including expanded analytics and intelligent automation. Allyson Fryhoff, Director of Global Healthcare and Life Sciences at AWS, noted, “We are thrilled to support IQVIA’s Agentic AI platform with the full breadth of AWS’s cloud capabilities. Together, we aim to help the life sciences industry leverage the power of AI to support ongoing innovation in healthcare and achieve outcomes once thought impossible.” IQVIA’s use of AWS infrastructure reflects a broader industry shift toward agentic AI systems capable of improving efficiency and patient outcomes.

Read more